Has Benjamin Cullen received payments from drug or device companies?

Yes. Drug and device makers reported $21,815 in general payments to Benjamin Cullen across 218 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Benjamin Cullen did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Benjamin Cullen come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Benjamin Cullen

Foot & Ankle Surgery · San Diego, CANPI 1851652309

Payments from drug & device makers

$21,815in general payments, 2019–2025

Across 218 payments — averaging $100.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Synthes GmbH$8K
Arthrex$4K
Paragon 28, Inc.$2K
Stryker$1K
Modulated Imaging, Inc.$913
Integra Lifesciences Corporation$764
plus $6K from 47 others

What the payments were for

Consulting fees$3,31015%
Speaking & faculty fees$6,75031%
Travel & lodging$3,53716%
Food & beverage$8,00937%
Other$2091%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Synthes GmbH	16	$7,784
Arthrex	2	$3,750
Paragon 28, Inc.	8	$1,922
Stryker(2 entities)	20	$1,053
Modulated Imaging, Inc.	2	$913
Integra Lifesciences Corporation	13	$764
Boston Scientific	7	$576
Smith+Nephew	15	$407
Nevro Corp.	6	$359
Acumed LLC	6	$357
Aroa Biosurgery Incorporated	6	$287
AbbVie	10	$259
Treace Medical Concepts, Inc.	5	$246
Amgen(2 entities)	2	$246
Johnson & Johnson	7	$194
Biotissue Holdings Inc.	5	$183
Advanced Oxygen Therapy Inc.	4	$173
Elevate Surgical Co	8	$172
Kerecis Limited	2	$168
Melinta Therapeutics, LLC	3	$152
Trimed, Inc.	3	$146
Paratek Pharmaceuticals, Inc.	6	$144
Zimmer Biomet	5	$141
Acera Surgical, Inc.	6	$123
Musculoskeletal Transplant Foundation Inc.	1	$105
Anika Therapeutics, Inc.	2	$101
Orpyx Medical Technologies US Inc.	1	$94
SPR Therapeutics, Inc	3	$76
Bioventus LLC	3	$75
Mimedx Group, Inc.	3	$66
Misonix Inc	4	$65
Dynasplint Systems Inc.	3	$59
Avita Medical Americas, LLC	1	$57
Medline Industries LP	3	$57
Tactile Systems Technology Inc	4	$55
Medtronic	2	$53
Medshape, Inc.	2	$51
Arthrosurface Incorporated	2	$45
Zyla Life Sciences, Inc.	3	$39
In2bones USA, LLC	1	$38
Radius Health, Inc.	1	$35
Abbott	1	$25
Davol Inc.	1	$24
Pacira Pharmaceuticals Incorporated	1	$23
Reprise Biomedical, Inc.	1	$21
Merck	1	$19
Averitas Pharma Inc.	1	$18
Bsn Medical Inc	1	$18
Organogenesis Inc.	1	$17
Axogen	1	$17
Orthofix Medical, Inc.	1	$16
Fusion Orthopedics USA, LLC	1	$15
Medartis Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,815 in reported general payments places this provider in the 90th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California →

Medicare billing

Part B allowed, 2024

$235,791

Medicare patients

385

Services billed

2,105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	20	$397
Terbinafine Hcl	15	$265
Clotrimazole	17	$259
Gabapentin	22	$189
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	29	$151
Triamcinolone Acetonide	12	$102
Methylprednisolone	26	$94
Doxycycline Hyclate	12	$47
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	11	$22

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in San Diego

Gary MulderSan Diego$262K
John ZimmermanBakersfield$4.6M
Eric GizaSacramento$3.7M
Thomas HarrisPasadena$3M
Felix SigalLos Angeles$2.2M
Thomas ChangSanta Rosa$2.1M
Michael CoughlinSan Francisco$1.6M
Vladimir ZeetserEncino$677K
Jason NowakRedding$526K
Candice BradyCamarillo$462K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →